Latest Posts
About This Stock
More About This Stock
Read
Read
Read
70 Firms Going Ex-Dividend Next Week, Including Walmart, BP And Pfizer
Article By:
Timothy J. McIntosh
Saturday, May 1, 2021 8:28 PM EDT
There are several well known large cap stocks going ex-dividend next week. Ex-dividend dates are important to dividend investors because one must own a stock prior to its ex-dividend date in order to be eligible to receive its next dividend.
E Daily Stock Analysis: Sanofi (SNY)
Article By:
Fredrik Arnold
Wednesday, April 28, 2021 5:58 AM EDT
Sanofi's price per share closed at $51.50 yesterday. One year ago its price was $49.87.
In this article: SNY
E Daily Stock Analysis: Sanofi
Article By:
Fredrik Arnold
Sunday, April 4, 2021 7:55 PM EDT
Should Sanofi's stock trade in the range of $40 to $65 this year, its recent $49.67 price might rise by $10.64 to reach $60.00 by April 5, 2022.
In this article: SNY
There Is Beta In Protalix Stock Due To PRX-102
Isn't that made by Sanofi $SNY?
Protalix BioTherapeutics Pipeline Progress
#Protalix clearly has a lot of potential but there's a limited number of people who will need this drug. So the real question is how much of a dent will they put into #Sanofi's market share. $PLX $SNY
Protalix BioTherapeutics Pipeline Progress
My pleasure. What's more important than how prevalent the disease is, is how much money #Protalix can make on its new drug. It's competitor, #Sanofi ($SNY) makes $1 billion in revenue annually on their drug. Protalix's sounds like a more promising alternative. I'd definitely rate $PLX a buy.